Cannabis use improves retention and sustained virological response in patients on therapy for hepatitis C

2006, Number 4

Rev Gastroenterol Mex 2006; 71 (4)

Marín-López E

Language: Spanish
References: 5
Page: 548-549
PDF size: 0. Kb.

Text Extraction

No abstract

REFERENCES

Kumar RN, Chambers WA, Pertwee RG. Pharmacological actions and therapeutics uses of cannabis and cannabinoids. Anaesthesia 2001; 56: 1059-68.
Noyes R Jr, Brunk SF, Baram DA, et al. Analgesic effect of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther 1975; 18: 84-9.
Hezode C, Roudot-Thoraval F, Nguyen S, et al. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology 2005; 42: 63-71.
Ishida JH, Chengshi J, Bacchetti P, et al. Influence of cannabis use on severity of hepatitis C disease. Hepatology 2006; 44: 211A.
Julien B, Greneard P, Texeira-Clerc F, et al. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 2005; 128: 742-55.